NCT06218303 2026-03-12
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
University of Pittsburgh
Phase 1 Recruiting
Clinical Trials
1 trialsPhase 1 × Carcinoma, Intraductal, Noninfiltrating × Selective Estrogen Receptor Modulators × Clear all